Surgery Partners, Inc. Experiences Revision in Stock Evaluation Amid Market Performance Shifts

Surgery Partners, Inc., a small-cap player in the hospital industry, has recently undergone a technical trend adjustment, reflecting shifts in its market performance metrics. The company's current stock price stands at $21.85, slightly above the previous close of $21.59. Over the past year, Surgery Partners has experienced significant volatility, with a 52-week high of $33.37 and a low of $18.87.
In terms of technical indicators, the MACD shows a mixed picture, with a mildly bullish outlook on a weekly basis but bearish on a monthly scale. The Relative Strength Index (RSI) indicates no clear signals for both weekly and monthly assessments. Bollinger Bands suggest a sideways trend weekly, while the monthly perspective leans bearish. Daily moving averages reflect a bearish sentiment, and the On-Balance Volume (OBV) is bearish for both weekly and monthly evaluations.

When comparing the company's performance to the S&P 500, Surgery Partners has shown varied returns. Over the past week, the stock returned 1.06%, contrasting with a decline of 0.31% for the S&P 500. However, over longer periods, such as one year and three years, the company has lagged behind the index, with returns of -32.16% and -8.15%, respectively. This evaluation revision highlights the challenges Surgery Partners faces in a competitive market landscape.